Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction

[1]  B. Zinman,et al.  Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience , 2018, Diabetes Care.

[2]  P. Kudenchuk,et al.  Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes , 2018, European journal of heart failure.

[3]  B. Zinman,et al.  DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality , 2017, Diabetologia.

[4]  S. Solomon,et al.  Declining Risk of Sudden Death in Heart Failure , 2017, The New England journal of medicine.

[5]  Hans Eiskjær,et al.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[6]  Paul L Hess,et al.  Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  M. Gheorghiade,et al.  Management of comorbid diabetes mellitus and worsening heart failure. , 2014, JAMA.

[8]  A. Moss,et al.  Influence of Diabetes Mellitus on Inappropriate and Appropriate Implantable Cardioverter-Defibrillator Therapy and Mortality in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT) Trial , 2013, Circulation.

[9]  Stephen B Wheatcroft,et al.  Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology , 2013, Diabetes & vascular disease research.

[10]  Karl Swedberg,et al.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. , 2008, European heart journal.

[11]  A. Jánosi,et al.  Rosuvastatin in older patients with systolic heart failure. , 2007, The New England journal of medicine.

[12]  A. Waldo.  Sudden Death in Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or BothSolomon SD, for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators (Brigham and Women's Hosp, Boston; et al) N Engl J Med 352:2581-2588, 2005§ , 2006 .

[13]  A. Moss,et al.  Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus. , 2005, The American journal of cardiology.

[14]  S. Solomon,et al.  Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.

[15]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[16]  K. Dickstein,et al.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.

[17]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[18]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[19]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[20]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[21]  N. Hardin,et al.  The myocardial and vascular pathology of diabetic cardiomyopathy. , 1996, Coronary artery disease.

[22]  A. Shehadeh,et al.  Cardiac consequences of diabetes mellitus , 1995, Clinical cardiology.

[23]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.